Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine whether rosuvastatin is effective in the management of moderate head injury by improving amnesia and orientation.


Clinical Trial Description

The head injury is a frequent problem of health, which produces high morbid-mortality. Today is the main cause of death and disability between 18 and 40 years. In addition it originates expensive expenses in health care systems.

Head injury produces damage by primary mechanisms related to impact, then by biochemical ways which are activated and they carry to secondary damage. Many studies have been conducted for explaining secondary injury, the majority conclude there is a kind of ischemic lesion related maybe with changes in cerebral flow and metabolism. The management today is trying to avoid progression in secondary damage without good outcome. Many drugs and measures has been ineffective.

In the last years has been demonstrated in head injury microvascular damage like stroke. Statins o inhibitors of HMG CoA reductase are drugs used in dyslipidemia, frequently for reduction in LDL. Experimental and clinical studies in stroke have shown improvement in outcome. The toxicity related to statin is myopathy and hepatopathy, both with low incidence without fatal cases. Rosuvastatin has been postulated be the most powerful with longest life and toxicity similar to another statins.

We have designed this study for demonstrate if the administration of rosuvastatin in the first 24 hours and by 10 days has improvement in amnesia and orientation, furthermore outcome. ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00329758
Study type Interventional
Source Universidad Autonoma de San Luis Potosí
Contact
Status Completed
Phase Phase 2
Start date July 2006
Completion date October 2007

See also
  Status Clinical Trial Phase
Terminated NCT00754169 - Warfighter Head Injury Study N/A
Completed NCT03164434 - Influence of Drainage on EVD ICP-signal
Completed NCT00993252 - Canadian Computed Tomography (CT) Head Rule Study Phase 3
Active, not recruiting NCT03441867 - Neuroimaging Biomarker for Seizures N/A
Active, not recruiting NCT05400551 - Craneofacial Injuries in Rink Hockey Athletes
Completed NCT00295074 - The Effect of Mild Traumatic Brain Injury on Recovery From Injury N/A
Completed NCT00001192 - Neuropsychological Evaluation of Psychiatric and Neurological Patients N/A
Recruiting NCT05326555 - Dynamic Vision Testing and Concussion Management Dream Team 65
Completed NCT03674398 - Aerobic Exercise and Cognitive Training Effects on Postconcussive Symptomology N/A
Completed NCT02650765 - S100 Biomarker in the Acute Management of Mild Head Injuries
Completed NCT02368366 - Comparative Effectiveness of Family Problem-Solving Therapy (F-PST) for Adolescent TBI N/A
Active, not recruiting NCT05629169 - Video Review of the Frequency and Assessment of Head Impacts During the FIFA World Cup 2022TM
Completed NCT02357186 - Broad Validation Study of a Management Algorithm Mild Head Injury in Children
Recruiting NCT05562050 - Characteristics of the Anosmic Olfactory Mucosa
Recruiting NCT04212754 - Management and Outcomes Following Emergency Surgery for Traumatic Brain Injury
Recruiting NCT06370520 - Screening Emotions in Adolescents at the Hospital for mTBI
Completed NCT02752711 - Validation of the PECARN Clinical Decision Rule for Children With Minor Head Trauma N/A
Recruiting NCT05663034 - CBT-I vs. MBTI for Traumatic Brain Injury (TBI)-Related Insomnia and Post-Traumatic Stress Symptoms N/A
Completed NCT04499937 - ReCoUPS: Post-Concussion Patient Reports N/A
Completed NCT01858675 - Biomarkers Correlation With Volemia N/A